DEL VECCHIO, SILVANA
 Distribuzione geografica
Continente #
NA - Nord America 2.151
EU - Europa 1.007
AS - Asia 806
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 4.015
Nazione #
US - Stati Uniti d'America 2.105
SG - Singapore 459
IT - Italia 338
CN - Cina 298
UA - Ucraina 153
FI - Finlandia 125
IE - Irlanda 119
DE - Germania 92
SE - Svezia 69
CI - Costa d'Avorio 48
CA - Canada 46
NL - Olanda 46
GB - Regno Unito 39
IN - India 15
VN - Vietnam 12
HK - Hong Kong 10
BE - Belgio 9
FR - Francia 7
KR - Corea 5
RU - Federazione Russa 3
TR - Turchia 3
EU - Europa 2
IR - Iran 2
IS - Islanda 2
BG - Bulgaria 1
DK - Danimarca 1
ID - Indonesia 1
JP - Giappone 1
LV - Lettonia 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
Totale 4.015
Città #
Singapore 378
Chandler 322
Jacksonville 198
Princeton 125
Millbury 124
Boston 112
Woodbridge 107
Santa Clara 100
Naples 91
Nanjing 85
Wilmington 68
Ashburn 54
Amsterdam 46
Ottawa 40
Houston 37
Ann Arbor 34
Beijing 34
Nanchang 34
Des Moines 30
Napoli 28
Hebei 27
Shenyang 25
Tianjin 25
Lawrence 21
Dublin 19
Jiaxing 19
Norwalk 18
Changsha 14
Milan 13
Dong Ket 12
Falls Church 12
Boardman 11
Kronberg 10
Rome 9
Hong Kong 7
Kunming 7
Seattle 7
Fairfield 6
Pune 6
Dearborn 5
Toronto 5
Zhengzhou 5
Bacoli 4
Courcelles 4
Frankfurt am Main 4
Orange 4
San Francisco 4
San Nicola la Strada 4
Washington 4
Caserta 3
Casoria 3
Castellammare Di Stabia 3
Crispano 3
Ghent 3
Giugliano in Campania 3
Helsinki 3
Lappeenranta 3
Ahmedabad 2
Albignasego 2
Bari 2
Bergamo 2
Brindisi 2
Brussels 2
Capodrise 2
Cava 2
Cesano Maderno 2
Columbus 2
Daejeon 2
Frattamaggiore 2
Guangzhou 2
Hangzhou 2
Indiana 2
Lacco Ameno 2
Los Angeles 2
Mashhad 2
Mumbai 2
Nocera Inferiore 2
Osimo 2
Portici 2
Redwood City 2
Reggio Nell'emilia 2
Reykjavik 2
Rimini 2
Santi Cosma e Damiano 2
Sarno 2
Shanghai 2
Shenzhen 2
Stockholm 2
Tolentino 2
Venezia 2
Villarosa 2
Arezzo 1
Augusta 1
Avigliano 1
Belgrade 1
Bellona 1
Bloomfield 1
Bologna 1
Castel Volturno 1
Changchun 1
Totale 2.459
Nome #
Tumor induced osteomalacia: a systematic review and individual patient's data analysis 66
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 65
99mTc-MIBI in the evaluation of breast cancer biology 60
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma 55
Investigation of integrin expression in cancer stem cells isolated from glioblastoma patients 51
Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma 48
Washout of 99mTc-Sestamibi in predicting response to chemotherapy in patients with multiple myeloma. 48
Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines. 47
Epidermal growth factor (EGFR) and Transferrin (TRFR) receptor upregulation is induced by arabinoside cytosine (ARA-C) on human tumor cells. 47
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 46
Functional imaging of multidrug resistance in breast cancer. 45
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 44
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 44
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 43
Molecular imaging of tumor microenvironment: challenges and perspectives 42
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study 41
Combined SPECT/CT and PET/CT for breast imaging 41
Scintigraphic detection of multidrug resistance in cancer 40
111In-pentetreotide scintigraphy:procedure guidelines for tumor imaging 40
PET/CT in cancer research: from preclinical to clinical applications. 40
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma 40
Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients 40
Nuclear imaging in cancer theranostic 39
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 39
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcima 39
99mTc-MIBI in the evaluation of breast cancer biology 39
Nuclear Imaging of Apoptosis in Animal Tumor Models 37
Vitronectin binding to urokinase receptor in human breast carcinoma 37
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 37
Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors 37
Urokinase receptor interacts with avb5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer 36
Tumor clearance of Technetium 99m-Sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer 36
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw 36
Detection of leptomeningeal involvement by 18F-FDG-PET/CT in a patient with non-Hodgkin lymphoma 36
Scintimammography with 99mTc-MIBI versus dynamic MRI forn non-invasive characterization of breast masses 35
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 35
99mTc-MIBI uptake is reduced in Bcl-2 overexpressing MCF-7 breast cancer cells 34
FDG-PET/CT imaging during the Covid-19 emergency: a southern Italian perspective 34
Heterogeneity of glycolytic phenotype determined by 18F-FDG PET/CT using coefficient of variation in patients with advanced non-small cell lung cancer 33
Technetium 99m sestamibi in multiple myeloma 33
Radiolabeling approaches for cholecystokinin B receptor imaging. 33
Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up 33
Radiolabeling approches for cholecystokinin B receptor imaging 33
Impact of COVID-19 pandemic on 2-[18F]FDG PET/CT imaging work-flow in a single medical institution: comparison among the three Italian waves 33
MIBI as prognostic factor in breast cancer 32
Annual Congress of the European Association of Nuclear Medicine Munich 2008 32
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer 32
Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma 32
Fractional retention of 99mTc-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. 31
In vivo detection of multidrug-resistant (MDR1) phenotype by 99mTc-Sestamibi scan in untreated breast cancer patients. 31
18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma. 31
Distribution of mediastinal lesions across multi-institutional, international, radiology databases 31
ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors 30
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 30
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma 30
Prediction of 2-[18F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study 29
Mammoscintigrafia e carcinoma mammario 29
Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization 29
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma 29
Molecular imaging: High-resolution detectors for early diagnosis and therapy monitoring of breast cancer. 29
Permeabilità bronchiale transepiteliale. Basi funzionali ed implicazioni cliniche. 29
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 29
In Vitro and In Vivo Characterization of Indium-111 and Technetium-99m Labeled CCK-8 Derivatives for CCK-B Receptor Imaging 28
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 28
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 28
Metabolic tumor volume assessed by 18F-FDG-PET/CT for the prediction of outcome in patients with multiple myeloma 28
Translational molecular imaging in exocrine pancreatic cancer. 28
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 27
Anti-murine antibody response to mouse monoclonal antibodies: clinical findings and implications 27
Molecular breast imaging: First results from Italian-National-Institute-of-Health clinical trials. 27
Use of 99mTc-sestamibi scintigraphy in multiple myeloma 26
Evaluation of the side effects of chemotherapy and radiotherapy on other organs 26
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3. 26
Avid (67)Ga uptake in multiple myeloma relapsing after bone marrow transplant. 26
La Medicina Nucleare in Oncologia 26
A new role for nuclear medicine in multiple myeloma. 26
Automatic radiosynthesis of [F-18]-FBCHO-maleimide linker for affibody labelling 26
99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis. 26
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. 26
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma 25
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. 25
99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine 25
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. 25
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 25
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives. 25
Preclinical imaging in targeted cancer therapies. 24
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau disease. 24
Molecular imaging: the emerging role of optical imaging in nuclear medicine. 24
In vitro receptor imaging for characterization of human solid tumors. 23
European Association of Nuclear Medicine 23
A new and selective radiolabeled alpha(v)beta 3 peptide antagonist as tracer in tumor diagnosis 23
F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma 23
Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC 23
Endobronchial administration of iodine-131 B72.3 monoclonal antibody in patients with lung cancer. 22
3'-Deoxy-3'-18F-Fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non–small cell lung cancer 22
A new and selective radiolabeled alpha(V)beta(3) peptide antagonist as tracer in tumor diagnosis 22
Combined imaging with 18F-FDG-PET/CT and 111In-labeled Octreotide SPECT for evaluation of thymic epithelial tumors 22
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 22
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells 22
SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer 21
Totale 3.307
Categoria #
all - tutte 21.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020213 0 0 0 0 37 9 4 1 16 16 48 82
2020/2021430 6 32 54 35 59 76 39 13 47 13 36 20
2021/2022722 10 1 7 1 10 29 11 22 114 38 145 334
2022/2023769 162 57 14 64 95 88 4 71 122 48 38 6
2023/2024616 43 82 65 41 41 22 23 83 24 20 119 53
2024/2025617 215 273 11 41 77 0 0 0 0 0 0 0
Totale 4.190